H. Bertz

发表

A competing risks analysis of bloodstream infection after stem‐cell transplantation using subdistribution hazards and cause‐specific hazards

Martin Schumacher, Jan Beyersmann, Markus Dettenkofer, 2007, Statistics in medicine.

Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD

H. Greinix, M. Gosau, S. Elad, 2011, Clinical Oral Investigations.

Outcomes of Invasive Infection due to Vancomycin-Resistant Enterococcus faecium during a Recent Outbreak

W. Kern, D. Jonas, H. Bertz, 2009, Infection.

Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.

A. Gratwohl, K. Dilger, J. Finke, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rehabilitation after Allogeneic Haematopoietic Stem Cell Transplantation: A Special Challenge

H. Bertz, 2021, Cancers.

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)

J. Duyster, J. Finke, G. Ihorst, 2018, BMC Cancer.

Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients

W. Kreisel, J. Finke, H. Bertz, 2011, Bone Marrow Transplantation.

Endurance and resistance training in patients with acute leukemia undergoing induction chemotherapy—a randomized pilot study

A. Gollhofer, H. Dickhuth, H. Bertz, 2018, Supportive Care in Cancer.

Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease

J. Duyster, F. Scherer, J. Finke, 2020, Bone Marrow Transplantation.

Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January−December 2016

H. Rohde, S. Peter, P. Higgins, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

J. Duyster, R. Wäsch, J. Finke, 2020, Bone Marrow Transplantation.

Ruxolitinib–ECP combination treatment for refractory severe chronic graft-versus-host disease

R. Wäsch, J. Finke, G. Ihorst, 2020, Bone Marrow Transplantation.

The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland.

E. Holler, H. Greinix, A. Lawitschka, 2011, Deutsches Arzteblatt international.

Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation

C. Schmoor, J. Finke, R. Wäsch, 2016, Bone Marrow Transplantation.

5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft

M. Lübbert, R. Wäsch, J. Finke, 2015, Bone Marrow Transplantation.

Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting

R. Claus, M. Lübbert, R. Wäsch, 2010, Bone Marrow Transplantation.

Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center

W. Vach, K. Kaier, K. de With, 2014, BMC Infectious Diseases.

Monitoring for compliance with a ketogenic diet: what is the best time of day to test for urinary ketosis?

H. Bertz, P. Urbain, 2016, Nutrition & Metabolism.

Hematological and Oncological Emergencies

H. Henß, H. Bertz, B. Lubrich, 2008, Concise Manual of Hematology and Oncology.

Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD

H. Greinix, P. Häusermann, A. Lawitschka, 2015, Bone Marrow Transplantation.

Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a controlled cross-over pilot study

S. Zorn, G. Ihorst, B. Rautenberg, 2020, BMC Cancer.

Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation

A. Prasse, R. Wäsch, J. Finke, 2013, Bone Marrow Transplantation.

Treatment with granulocyte colony‐stimulating factor increases interleukin‐1 receptor antagonist levels during engraftment following allogeneic stem‐cell transplantation

J. Finke, H. Bertz, M. Schwabe, 2004, European journal of clinical investigation.

Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).

T. Zenz, M. Rössle, J. Finke, 2001, Liver.

Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic graft‐versus‐host disease

L. Hofbauer, E. Holler, H. Greinix, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia

J. Finke, H. Bertz, A. Spyridonidis, 2012, Bone Marrow Transplantation.

A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention

A. Gollhofer, C. Maurer, J. Lambeck, 2019, BMC Neurology.

Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts, unselected PBPC grafts or BM grafts

C. Schmoor, J. Finke, D. Behringer, 1999, Bone Marrow Transplantation.

Remission of refractory Crohn's disease by high‐dose cyclophosphamide and autologous peripheral blood stem cell transplantation

W. Kreisel, A. Stallmach, J. Finke, 2012, Alimentary pharmacology & therapeutics.

Role of antioxidants in buccal mucosa cells and plasma on the incidence and severity of oral mucositis after allogeneic haematopoietic cell transplantation

H. Biesalski, H. Bertz, C. Lambert, 2012, Supportive Care in Cancer.

Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation

J. Held, C. Thornton, H. Bertz, 2013, Infection.

Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin.

C. Schmoor, J. Finke, H. Bertz, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies

J. Finke, R. Zeiser, H. Bertz, 2004, Annals of Hematology.

Matched a nd M ismatched A llogeneic S tem-Cell Transplantation F rom U nrelated D onors U sing C ombined Graft-Versus-Hos t D isease P rophylaxis I ncluding R abbit Anti-T L ymphocyte G lobulin

C. Schmoor, J. Finke, H. Bertz, 2003 .

Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives

J. Finke, R. Zeiser, H. Bertz, 2004, Bone Marrow Transplantation.

[Hepatitis B reactivation following immunosuppressive therapy and screening adherence: a neglected problem?].

W. Offensperger, H. Bertz, J. Borde, 2012, Deutsche medizinische Wochenschrift.

Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing stem cell transplantation.

R. Wäsch, G. Ihorst, M. Engelhardt, 2020, Journal of geriatric oncology.

Sinus venous thrombosis: an unusual cause for neurologic symptoms after bone marrow transplantation under immunosuppression.

J. Finke, H. Bertz, J. Laubenberger, 1998, Transplantation.

High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.

C. Waller, J. Finke, M. Engelhardt, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients

J. Schulte‐Mönting, C. Heining, J. Finke, 2007, Bone Marrow Transplantation.

Bioavailability of vitamin D2 from UV-B-irradiated button mushrooms in healthy adults deficient in serum 25-hydroxyvitamin D: a randomized controlled trial

G. Ihorst, H. Biesalski, H. Bertz, 2011, European Journal of Clinical Nutrition.

Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites.

C. Eng, K. Schmid, H. Neumann, 2011, The Journal of clinical endocrinology and metabolism.

Interleukin-8, Neutropenia, and Graft Failure in Human Stem Cell Transplantation

J. Finke, H. Bertz, M. Schwabe, 2004, Transplantation.

Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.

A. Prasse, R. Wäsch, J. Finke, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematology and Hemostasis

R. Engelhardt, D. Berger, J. Finke, 2008, Concise Manual of Hematology and Oncology.

Influenza virus A(H1N1)pdm09 hemagglutinin polymorphism and associated disease in southern Germany during the 2010/11 influenza season

U. Kontny, M. Panning, H. Bertz, 2013, Archives of Virology.

Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation

A. Gratwohl, A. Bosi, V. Leblond, 1998 .

High- V ersus S tandard-Dose F ilgrastim ( rhG-CSF) for M obilization o f P eripheral-Blood P rogenitor C ells From A llogeneic D onors a nd C D34 1 Immunoselection

C. Waller, M. Engelhardt, H. Bertz, 1999 .

In vitro and in vivo characterization of graft‐versus‐tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation

A. Mackensen, J. Finke, S. Hoegerle, 2002, International journal of cancer.

Improvement in the outcome of invasive fusariosis in the last decade.

E. Anaissie, L. Pagano, M. Nucci, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project.

H. Rüden, P. Gastmeier, M. Dettenkofer, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis

T. Boch, W. Hofmann, P. M. Deckert, 2019, Mycoses.

Aspergillus PCR-Based Investigation of Fresh Tissue and Effusion Samples in Patients with Suspected Invasive Aspergillosis Enhances Diagnostic Capabilities

C. Heussel, W. Hofmann, H. Wolf, 2013, Journal of Clinical Microbiology.

Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples

W. Hofmann, H. Wolf, S. Krause, 2012, European journal of haematology.

Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte‐colony stimulating factor accelerate both neutrophil and platelet recovery after high‐dose VP16, ifosfamide and cisplatin

L. Kanz, W. Brugger, R. Mertelsmann, 1993, British journal of haematology.

Decitabine (DAC) in Combination with Donor Lymphocyte Infusions (DLIs) Can Induce Remissions of Overt Aml Relapses after Allogeneic Transplantation

R. Claus, M. Lübbert, R. Wäsch, 2016 .

Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML

C. Schmoor, J. Finke, R. Wäsch, 2013, Bone Marrow Transplantation.

Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.

N. Kröger, G. Kobbe, R. Kelsch, 2018, Biology of Blood and Marrow Transplantation.

Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity

R. Mertelsmann, J. Finke, H. Bertz, 1997, Bone Marrow Transplantation.

Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German–Austrian–Swiss Consensus Conference on Clinical Practice in Chronic GVHD

A. Heiligenhaus, B. Seitz, H. Greinix, 2012, Cornea.

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

H. Einsele, M. Egger, C. Schmoor, 2009, The Lancet. Oncology.

Non-intensive treatment with low-dose 5-aza-2′-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients

R. Claus, M. Lübbert, R. Wäsch, 2009, Bone Marrow Transplantation.

Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

C. Schmoor, P. Dreger, G. Kobbe, 2022, Bone Marrow Transplantation.

Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies.

E. Holler, J. Finke, G. Ihorst, 2008, Blood.

Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation

J. Duyster, F. Scherer, J. Finke, 2022, Cancers.

Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.

R. Wäsch, J. Finke, G. Ihorst, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.

L. Kanz, W. Brugger, R. Mertelsmann, 1996, Bone marrow transplantation.

Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors

C. Schmoor, R. Mertelsmann, R. Mertelsmann, 1999, Bone Marrow Transplantation.

Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantation

J. Finke, J. Duyster, H. Bertz, 2016, Bone Marrow Transplantation.

Relationship between Psychosocial Distress, Treatment Need and Use of Psychotherapeutic Interventions within a Psychosomatic Liaison Service in Hematological Oncology

K. Fritzsche, H. Bertz, B. Stein, 2004, Oncology Research and Treatment.

Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies

H. Einsele, H. Oettle, D. Niederwieser, 2003, Annals of Hematology.

Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation

C. Waller, A. Lindemann, J. Finke, 2004, Bone Marrow Transplantation.

Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen.

C. Waller, R. Mertelsmann, M. Hardung, 1996, Bone marrow transplantation.

Course of serum 25-hydroxyvitamin D3 status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation

G. Ihorst, H. Biesalski, H. Bertz, 2012, Annals of Hematology.

Successful treatment of severe acute intestinal graft-versus-host resistant to systemic and topical steroids with alemtuzumab.

M. Egger, J. Finke, H. Bertz, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD

W. Kreisel, R. Greinwald, J. Finke, 1999, Bone Marrow Transplantation.

Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract

R. Wäsch, J. Finke, G. Ihorst, 2022, Bone Marrow Transplantation.

Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.

A. Elmaagacli, E. Holler, H. Greinix, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Central venous catheter-associated bloodstream infection and colonisation of insertion site and catheter tip. What are the rates and risk factors in haematology patients?

C. Schmoor, A. Widmer, D. Heim, 2010, Annals of Hematology.

colonisation of insertion-site and catheter tip. What are the rates and risk

C. Schmoor, A. Widmer, D. Heim, 2010 .

Principals of Nutrition after Surgical Procedure

H. Bertz, A. Engelhardt, 2012 .

Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation

W. Kreisel, J. Finke, H. Bertz, 2003, Bone Marrow Transplantation.

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

C. Lengerke, N. Kröger, M. Lübbert, 2015, Leukemia.

Group for Blood and Marrow Transplantation Marrow Transplantation: A Prospective Cohort Study of the European Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or

A. Gratwohl, A. Bosi, V. Leblond, 2013 .

Human Metapneumovirus Infection in a Hematopoietic Stem Cell Transplant Recipient with Relapsed Multiple Myeloma and Rapidly Progressing Lung Cancer

W. Kern, D. Neumann-Haefelin, H. Bertz, 2006, Journal of Clinical Microbiology.

Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis

M. Lübbert, J. Duyster, R. Wäsch, 2021, Annals of Hematology.

Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning

R. Wäsch, H. Veelken, J. Finke, 2000, Bone Marrow Transplantation.

A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT

R. Wäsch, J. Finke, G. Ihorst, 2021, Annals of Hematology.

ESPEN expert group recommendations for action against cancer-related malnutrition.

D. Lobo, P. Calder, P. Vaupel, 2017, Clinical nutrition.

Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation

F. Hufert, G. Pantazis, J. Finke, 2004, Bone Marrow Transplantation.

A novel GVHD-prophylaxis with low-dose alemtuzumab in allogeneic sibling or unrelated donor hematopoetic cell transplantation: the feasibility of deescalation.

R. Wäsch, J. Finke, C. Grüllich, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bilateral optic neuropathy after bone marrow transplantation and cyclosporin A therapy

J. Gerling, H. Bertz, S. Walter, 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation

M. Lübbert, H. Bertz, K. Drognitz, 2013, Annals of Hematology.

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

A. Glasmacher, R. Andreesen, C. Junghanss, 2006, The Journal of antimicrobial chemotherapy.

A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation

J. Finke, C. Grüllich, H. Bertz, 2008, Bone Marrow Transplantation.

Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.

R. Wäsch, J. Finke, G. Ihorst, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation

R. Wäsch, J. Finke, G. Ihorst, 2010, Bone Marrow Transplantation.

Reduced intensity conditioning compared to standard conditioning preserves the in vitro growth capacity of bone marrow stroma, which remains of host origin.

R. Wäsch, J. Finke, D. Behringer, 2005, Stem cells and development.

Analysis of the efficiency and costs of antifungal prophylaxis and mycological diagnostics in patients undergoing allogeneic haematopoietic cell transplantation: “real life” evaluation

J. Finke, H. Bertz, K. Drognitz, 2016, Annals of Hematology.

Diagnostic Performance of an Aspergillus-Specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis

W. Hofmann, S. Reuter, D. Buchheidt, 2013, PloS one.

Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect

J. Burger, R. Mertelsmann, J. Finke, 1997, Leukemia.

Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014.

A. Widmer, M. Weisser, M. Dettenkofer, 2018, The Journal of infection.

Spuriously raised cyclosporin concentrations drawn through polyurethane central venous catheter

C. Niemeyer, U. Duffner, H. Bertz, 1998, The Lancet.

A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation

J. Finke, H. Bertz, M. Waterhouse, 2014, Annals of Hematology.

Basement membrane antibodies in sera of haematopoietic cell recipients are associated with graft‐versus‐host disease

L. Bruckner-Tuderman, H. Bertz, S. Hofmann, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

ESPEN guidelines on nutrition in cancer patients.

Vickie Baracos, Jean-Charles Preiser, Stefan Mühlebach, 2017, Clinical nutrition.

Long-term follow-up after allogeneic stem cell transplantation.

Daniel Wolff, Anita Lawitschka, H. Greinix, 2015, Deutsches Arzteblatt international.

ESPEN practical guideline: Clinical Nutrition in cancer.

P. Ravasco, L. Oldervoll, S. Kaasa, 2021, Clinical nutrition.

Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.

Daniel Wolff, Anita Lawitschka, E. Holler, 2010, Brain : a journal of neurology.

Breakthrough Invasive Infection Due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a Stem Cell Transplant Patient Receiving Liposomal Amphotericin B and Caspofungin for Suspected Aspergillosis

W. Kern, J. Finke, D. Wagner, 2005, Infection.

Therapeutic Drug Monitoring of Posaconazole in Hematology Patients: Experience with a New High-Performance Liquid Chromatography-Based Method

M. Jung, K. Kümmerer, M. Engelhardt, 2010, Antimicrobial Agents and Chemotherapy.

Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation

H. Rüden, M. Dettenkofer, R. Babikir, 2003, Bone Marrow Transplantation.

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

H. Einsele, M. Kiehl, J. Vehreschild, 2016, Annals of Hematology.

Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial.

C. Schmoor, A. Gratwohl, A. Widmer, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature

D. Seidel, M. Hoenigl, R. Herbrecht, 2019, Mycoses.

Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation

T. Bley, G. Pantazis, B. Hackanson, 2005, Clinical transplantation.

Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002.

K. de With, W. Kern, S. Reuter, 2005, The Journal of antimicrobial chemotherapy.

Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation

H Rüden, M Schumacher, J Beyersmann, 2007, Bone Marrow Transplantation.

Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation.

W. Kreisel, J. Finke, A. Schmitt-Gräff, 2004, Transplantation.

Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation

J. Duyster, M. Follo, J. Finke, 2019, Clinical chemistry and laboratory medicine.

Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation

J. Duyster, M. Follo, J. Finke, 2017, Clinical chemistry and laboratory medicine.

Particular Treatment Procedures

A. Mackensen, U. Martens, F. Rosenthal, 2008, Concise Manual of Hematology and Oncology.

Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic hematopoietic cell transplantation in humans.

P. Fisch, J. Finke, A. Schmitt-Gräff, 2005, Blood.

Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation

E. Holler, R. Wäsch, H. Veelken, 2000, Bone Marrow Transplantation.

Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation.

R. Claus, M. Lübbert, J. Duyster, 2018, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia

J. Finke, H. Bertz, A. Spyridonidis, 2010, Leukemia.

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)

N. Kröger, G. Ehninger, M. Bornhäuser, 2003, Bone Marrow Transplantation.

Impact of a 6-week non-energy-restricted ketogenic diet on physical fitness, body composition and biochemical parameters in healthy adults

H. Bertz, A. Wehrle, P. Deibert, 2017, Nutrition & Metabolism.

Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome

J. Finke, B. Deschler, M. Engelhardt, 2004, Bone Marrow Transplantation.

Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index.

C. Waller, J. Finke, W. Lange, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

A. Gratwohl, A. Bosi, V. Leblond, 1998, Blood.

Phenotypical and functional analysis of donor lymphocyte infusion products after long-term cryopreservation.

J. Duyster, M. Follo, J. Finke, 2020, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Allogeneic bone marrow transplantation from unrelated donors using in vivo anti‐T‐cell globulin

C. Schmoor, R. Mertelsmann, R. Wäsch, 2000, British journal of haematology.

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

M. Caligiuri, C. Lengerke, B. Becher, 2018, Nature Medicine.

Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation

J. Finke, H. Biesalski, H. Bertz, 2013, Bone Marrow Transplantation.

Nutritional status and its impact on outcome in patients undergoing allogeneic haematopoietic cell transplantation and an experimental trial to improve the supply of a specific micronutrient

H. Breer, H. Biesalski, H. Bertz, 2012 .

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

H. Einsele, M. Egger, C. Schmoor, 2011, Blood.

Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin

C. Schmoor, R. Mertelsmann, R. Wäsch, 2000 .

German–Austrian–Swiss Consensus Conference on clinical practice in chronic graft‐versus‐host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD

P. Häusermann, A. Lawitschka, H. Bertz, 2011, The British journal of dermatology.

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD

E. Holler, H. Greinix, S. Pavletic, 2011, Bone Marrow Transplantation.

Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial.

C. Schmoor, D. Heim, G. Socié, 2017, The Lancet. Haematology.

Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation

R. Wäsch, J. Finke, H. Bertz, 2000, British journal of haematology.

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation

R. Wäsch, J. Finke, G. Ihorst, 2005, Leukemia.

Lowering the alemtuzumab dose in reduced intensity conditioning allogeneic hematopoietic cell transplantation is associated with a favorable early intense natural killer cell recovery.

J. Finke, H. Bertz, F. Gärtner, 2013, Cytotherapy.

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.

N. Kröger, O. Kuss, D. Niederwieser, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantation

R. Wäsch, J. Finke, R. Zeiser, 2005, Clinical transplantation.

Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation

R. Wäsch, J. Finke, M. Engelhardt, 2001, Annals of Hematology.

Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

H. Auner, S. Reuter, H. Wolf, 2012, Annals of Hematology.

Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation

H. Einsele, H. Auner, T. Südhoff, 2003, Annals of Hematology.

Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALL

J. Finke, H. Bertz, A. Spyridonidis, 2008, Bone Marrow Transplantation.

Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy.

A. Gollhofer, F. Baumann, G. Ihorst, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factor and quality of life analysis in 160 patients aged > or =60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation.

R. Wäsch, J. Finke, G. Ihorst, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cell-free DNA characteristics and chimerism analysis in patients after allogeneic cell transplantation.

J. Duyster, M. Follo, J. Finke, 2017, Clinical biochemistry.

Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.

H. Einsele, C. Schmoor, A. Zander, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of individualized communication skills training on physicians’ discussion of clinical trials in oncology: results from a randomized controlled trial

D. Terris, M. Wirsching, G. Ihorst, 2017, BMC Cancer.

Horizontal DNA transfer from donor to host cells as an alternative mechanism of epithelial chimerism after allogeneic hematopoietic cell transplantation.

J. Finke, H. Bertz, A. Spyridonidis, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation

R. Wäsch, J. Finke, G. Ihorst, 2020, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDS

M. Lübbert, R. Wäsch, J. Finke, 2016, Leukemia.

Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft

R. Wäsch, J. Finke, G. Ihorst, 2012, Bone Marrow Transplantation.

Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy

H. Bertz, A. Wehrle, C. Maurer, 2021, Annals of clinical and translational neurology.

Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies – a randomized controlled pilot study

A. Gollhofer, H. Bertz, A. Wehrle, 2018, BMC Cancer.

Results From a Pilot Study of Handheld Vibration: Exercise Intervention Reduces Upper-Limb Dysfunction and Fatigue in Breast Cancer Patients Undergoing Radiotherapy: VibBRa Study

A. Gollhofer, N. Volegova-Neher, H. Bertz, 2018, Integrative cancer therapies.

Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis

J. Finke, G. Ihorst, B. Deschler, 2018, Bone Marrow Transplantation.

Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia.

J. Finke, H. Bertz, K. Potthoff, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NT-pro-BNP: not the prognostic all-rounder in elderly patients undergoing allogeneic stem cell transplantation

R. Mertelsmann, R. Wäsch, J. Finke, 2012, Annals of Hematology.

Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

C. Schmoor, P. Dreger, G. Kobbe, 2022, Bone Marrow Transplantation.

Allogeneic S tem-Cell T ransplantation F rom R elated a nd Unrelated D onors i n O lder P atients W ith M yeloid L eukemia

J. Finke, H. Bertz, K. Potthoff, 2003 .

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens.

H. Veelken, J. Finke, H. Bertz, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantation.

J. Finke, R. Wäsch, H. Bertz, 2013, Transplantation proceedings.

The impact of pulmonary function in patients undergoing autologous stem cell transplantation

J. Duyster, R. Wäsch, J. Finke, 2021, Blood advances.

Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation

R. Wäsch, J. Finke, G. Ihorst, 2022, Vaccines.

Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life

H. Einsele, J. Duyster, R. Wäsch, 2018, Haematologica.

Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments

A. Gollhofer, G. Ihorst, H. Bertz, 2021, Bone Marrow Transplantation.

Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation.

J. Finke, H. Bertz, D. Pfeifer, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (> or = 60 years) with active myeloid malignancies.

J. Finke, G. Ihorst, C. Grüllich, 2005, Blood.

advanced hematologic malignancies allogeneic hematopoietic cell transplantation: particular activity against Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in

E. Holler, J. Finke, G. Ihorst, 2013 .

Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study

Jan A. Roth, A. Widmer, M. Dettenkofer, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS).

A. Widmer, M. Weisser, M. Dettenkofer, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Allogeneic hematopoietic cell transplantation for t-AML following liver transplantation from the same haploidentical donor

J. Finke, R. Zeiser, H. Bertz, 2009, Bone Marrow Transplantation.

Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation

J. Finke, G. Ihorst, H. Biesalski, 2012, Annals of Hematology.

Whole body vibration training during allogeneic hematopoietic cell transplantation—the effects on patients’ physical capacity

A. Gollhofer, H. Bertz, A. Wehrle, 2020, Annals of Hematology.

An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation.

F. Dimeo, J. Keul, R. Mertelsmann, 1996, Bone marrow transplantation.

Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation.

Roland Mertelsmann, L. Kanz, F. Dimeo, 1998 .

Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation

L. Kanz, F. Dimeo, J. Keul, 1997, Cancer.

Effects of a Non-Energy-Restricted Ketogenic Diet on Clinical Oral Parameters. An Exploratory Pilot Trial

J. Woelber, P. Ratka‐Krüger, K. Vach, 2021, Nutrients.

OP035 BIOAVAILABILITY OF VITAMIN D2 FROM UVB-IRRADIATED BUTTON MUSHROOMS IN HEALTHY ADULTS DEFICIENT IN SERUM 25-HYDROXYVITAMIN D (25OHD): A RANDOMIZED-CONTROLLED TRIAL

H. Biesalski, H. Bertz, P. Urbain, 2010 .

Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy

Jan A. Roth, A. Widmer, M. Dettenkofer, 2019, Infection.

Extent and time course of morphological changes of bone marrow induced by granulocyte‐colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donors

C. Altehoefer, N. Ghanem, H. Bertz, 2001, Journal of magnetic resonance imaging : JMRI.

Effect of individualized communication skills training on physicians’ discussion of clinical trials in oncology: results from a randomized controlled trial

D. Terris, M. Wirsching, G. Ihorst, 2017, BMC Cancer.

Development and evaluation of a checklist assessing communication skills of oncologists: the COM-ON-Checklist.

M. Wirsching, K. Fritzsche, H. Bertz, 2012, Journal of evaluation in clinical practice.

Specific training program improves oncologists' palliative care communication skills in a randomized controlled trial.

M. Wirsching, G. Ihorst, K. Fritzsche, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Statistical epidemic modeling with hospital outbreak data

M. Schumacher, M. Wolkewitz, M. Dettenkofer, 2008, Statistics in medicine.

Interprofessional evidence-based counselling programme for complementary and integrative healthcare in patients with cancer: study protocol for the controlled implementation study CCC-Integrativ

P. Martus, R. Stolz, S. Joos, 2022, BMJ Open.

Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: Case 1. Multiple myeloma relapse presenting as malignant pericardial effusion.

T. Bley, B. Hackanson, J. Finke, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful adoptive immunotherapy for relapse of AML 9 years after T‐cell‐depleted BMT

J. Finke, D. Bunjes, H. Bertz, 1998, British journal of haematology.

Screening and contact precautions – A survey on infection control measures for multidrug-resistant bacteria in German university hospitals

H. Rohde, Mathias W Pletz, S. Peter, 2017, Antimicrobial Resistance & Infection Control.

Principles of Medical Oncology

U. Martens, D. Berger, H. Henß, 2008 .

Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease

A. Schmitt-Graeff, D. Bettinger, R. Thimme, 2015, Annals of Hematology.

Fatal Leukoencephalopathy after Reduced-Intensity Allogeneic Stem Cell Transplantation

F. Feuerhake, T. Bley, S. Mielke, 2007, Oncology Research and Treatment.

An internal validation approach and quality control on hematopoietic chimerism testing after allogeneic hematopoietic cell transplantation

J. Finke, H. Bertz, R. Kunzmann, 2012, Clinical chemistry and laboratory medicine.

It’s never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trial

A. Gollhofer, G. Ihorst, H. Bertz, 2019, BMC Cancer.

Influenza virus A(H1N1)pdm09 hemagglutinin polymorphism and associated disease in southern Germany during the 2010/11 influenza season

U. Kontny, M. Panning, H. Bertz, 2013, Archives of Virology.

What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials

H. Bertz, A. Wünsch, C. Behrendt, 2010, Journal of Medical Ethics.

Covid‐19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany

C. Miething, J. Duyster, W. Kern, 2020, Cancer medicine.

Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies – a randomized controlled pilot study

A. Gollhofer, H. Bertz, A. Wehrle, 2018, BMC Cancer.

Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation

H. Bertz, E. Kotter, K. Enger, 2022, Annals of Hematology.

Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer

C. Schaefer-Prokop, F. Baron, M. Paesmans, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Environmental Contamination as an Important Route for the Transmission of the Hospital Pathogen VRE: Modeling and Prediction of Classical Interventions

M. Wolkewitz, M. Dettenkofer, H. Bertz, 2008 .

Impact of Donor-Recipient Histocompatibility and CMV-Mismatch on Outcome of Allogeneic Stem Cell Transplantation for AML and MDS: A Retrospective Registry Study of the German Stem Cell Transplant Registry (DRST) of the German Working Group for Blood and Marrow Transplantation (DAG-KBT)

N. Kröger, G. Kobbe, M. Bornhäuser, 2016 .

Balance impairments and neuromuscular changes in breast cancer patients with chemotherapy-induced peripheral neuropathy

A. Gollhofer, R. Ritzmann, K. Freyler, 2016, Clinical Neurophysiology.

Initially fewer bloodstream infections for allogeneic vs. autologous stem-cell transplants in neutropenic patients

M. Schumacher, J. Beyersmann, M. Dettenkofer, 2012, Epidemiology and Infection.

Addressing the Transition from Curative to Palliative Care: Concept and Acceptance of a Specific Communication Skills Training for Physicians in Oncology – COM-ON-p

M. Wirsching, K. Fritzsche, H. Bertz, 2010, Oncology Research and Treatment.

Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR

J. Duyster, M. Follo, J. Finke, 2016, Annals of Hematology.